Asmanex Twisthaler (mometasone furoate) / Merck (MSD) - LARVOL DELTA

Correct use of inhalers for asthma. (PubMed, Med Lett Drugs Ther) - No abstract available

Journal • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases

Drugs for asthma. (PubMed, Med Lett Drugs Ther) - No abstract available

Journal • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases

Comparison chart: Some inhaled drugs for treatment of asthma. (PubMed, Med Lett Drugs Ther) - No abstract available

Journal • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases

Using Filters to Estimate Regional Lung Deposition with Pressurized Metered Dose Inhalers. (PubMed, Pharm Res) - "The direct measurement of estimated regional deposition is possible when using the FBA. This method is far less resource intensive than existing methods and so may be useful both for comparison of generic alternatives and the development of innovative products."

Journal

Stress and Treatment Response in Puerto Rican Children With Asthma (clinicaltrials.gov) - P=N/A | N=249 | Completed | Sponsor: University of Pittsburgh | Recruiting ➔ Completed | Trial completion date: Dec 2022 ➔ May 2022

Trial completion • Trial completion date • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases

Study to Compare the Pharmacokinetics of Mometasone Furoate Alone and in Combination With Indacaterol in Patients ≥ 6 to < 12 Years Old With Asthma (clinicaltrials.gov) - P2 | N=32 | Completed | Sponsor: Novartis Pharmaceuticals | Recruiting ➔ Completed

Combination therapy • Trial completion • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases

Using Filters to Estimate Regional Lung Deposition with Dry Powder Inhalers. (PubMed, Pharm Res) - "Because of its design, the TB filter apparatus makes it possible to estimate regional deposition with inhalers directly using variable inhalation profiles without any additional equipment or changes to the experimental configuration. This method may be useful to expedite development of both innovative and generic drug products as it provides regional respiratory tract deposition estimates using fewer resources than exisiting methods."

Journal

Study to Compare the Pharmacokinetics of Mometasone Furoate Alone and in Combination With Indacaterol in Patients ≥ 6 to < 12 Years Old With Asthma (clinicaltrials.gov) - P2; N=32; Recruiting; Sponsor: Novartis Pharmaceuticals; Not yet recruiting ➔ Recruiting

Enrollment open • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases

Stress and Treatment Response in Puerto Rican Children With Asthma (clinicaltrials.gov) - P=N/A; N=300; Recruiting; Sponsor: University of Pittsburgh; Trial completion date: Dec 2021 ➔ Nov 2022; Trial primary completion date: Oct 2021 ➔ May 2022

Clinical • Trial completion date • Trial primary completion date • Asthma • Immunology • Pulmonary Disease • Respiratory Diseases

Pharmacokinetics of mometasone furoate delivered via two dry powder inhalers. (PubMed, Pulm Pharmacol Ther) - "PK characterization in a healthy volunteer PK study and subsequently an asthma study enabled selection of 80 μg (low), 160 μg (medium), and 320 μg (high) delivered via Breezhaler® as MF doses comparable to the 200 μg, 400 μg and 800 μg doses delivered by Twisthaler®, respectively, as part of QMF149 formulation development."

Journal • PK/PD data • Asthma • Immunology • Respiratory Diseases

Drugs for asthma. (PubMed, Med Lett Drugs Ther) - No abstract available

Journal • Asthma • Immunology • Respiratory Diseases

Expanded table: Correct use of inhalers for asthma. (PubMed, Med Lett Drugs Ther) - No abstract available

Journal • Asthma • Immunology • Respiratory Diseases

Expanded table: Some inhaled drugs for treatment of asthma. (PubMed, Med Lett Drugs Ther) - No abstract available

Journal • Asthma • Immunology • Respiratory Diseases

Study to compare the pharmacokinetics of mometasone furoate alone and in combination with indacaterol in patients ≥ 6 to < 12 years old with asthma (clinicaltrialsregister.eu) - P2; N=32; Ongoing; Sponsor: Novartis Pharma AG

Clinical • Combination therapy • New P2 trial • Asthma • Immunology • Pediatrics • Respiratory Diseases

Study to Compare the Pharmacokinetics of Mometasone Furoate Alone and in Combination With Indacaterol in Patients ≥ 6 to < 12 Years Old With Asthma (clinicaltrials.gov) - P2; N=32; Not yet recruiting; Sponsor: Novartis Pharmaceuticals

Clinical • Combination therapy • New P2 trial • Asthma • Respiratory Diseases

Drugs for COPD. (PubMed, Med Lett Drugs Ther) - No abstract available

Journal • Chronic Obstructive Pulmonary Disease • Infectious Disease • Tobacco Cessation

Comparison table: Inhaled corticosteroids for treatment of COPD. (PubMed, Med Lett Drugs Ther) - No abstract available

Journal • Chronic Obstructive Pulmonary Disease

Table: Correct Use of inhalers for COPD. (PubMed, Med Lett Drugs Ther) - No abstract available

Journal • Asthma • Chronic Obstructive Pulmonary Disease • Respiratory Diseases

"The struggle. #Asmanex @Merck lol" (@Meggles0728)

6 signs of hope for COPD: New treatments for seniors suffering from COPD (Caring) - "Every patient is different, and treatment depends on how many exacerbations a person with COPD is experiencing, says Byron Thomashow...But since all three medications treat different aspects of the disease, many people do best taking all of them. Anticholinergics like Spiriva work by relaxing the smooth muscles, preventing airway spasms."

Media quote • Chronic Obstructive Pulmonary Disease

Stress and Treatment Response in Puerto Rican Children With Asthma (clinicaltrials.gov) - P=N/A; N=300; Recruiting; Sponsor: University of Pittsburgh; Trial completion date: Jun 2021 ➔ Dec 2021; Trial primary completion date: Dec 2020 ➔ Oct 2021

Clinical • Trial completion date • Trial primary completion date • Asthma • Immunology • Respiratory Diseases

Once-daily outperforms twice-daily inhaled steroid in asthma (Medscape) - P=NA, N=11,841; Among FP patients more exacerbations were found than among MF patients (p=.0263) and more SABA fills in the postindex period (p<0.001); MF pateints also had more prescription fills, suggesting better adherence (p<.0001)

Clinical data • Asthma

SIENA: Steroids In Eosinophil Negative Asthma (clinicaltrials.gov) - P3; N=295; Completed; Sponsor: Milton S. Hershey Medical Center; Active, not recruiting ➔ Completed

Trial completion • Asthma • Biosimilar • Immunology • Respiratory Diseases

A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Patients With Asthma (clinicaltrials.gov) - P3; N=2222; Completed; Sponsor: Novartis Pharmaceuticals; Recruiting ➔ Completed; Trial primary completion date: Jul 2019 ➔ Nov 2018

Clinical • Trial completion • Trial primary completion date

A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Patients With Asthma (clinicaltrials.gov) - P3; N=2000; Recruiting; Sponsor: Novartis Pharmaceuticals; Trial primary completion date: Nov 2018 ➔ Jul 2019

Clinical • Trial primary completion date